Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 88

1.

[Resistance to the latest beta-lactams: mechanisms of acquisition and spread of resistance in Enterobacteriaceae].

Michel-Briand Y.

Bull Acad Natl Med. 2007 Jan;191(1):35-50; discussion 50-1. Review. French.

PMID:
17645106
2.

The pyocins of Pseudomonas aeruginosa.

Michel-Briand Y, Baysse C.

Biochimie. 2002 May-Jun;84(5-6):499-510. Review.

PMID:
12423794
3.

Uptake of pyocin S3 occurs through the outer membrane ferripyoverdine type II receptor of Pseudomonas aeruginosa.

Baysse C, Meyer JM, Plesiat P, Geoffroy V, Michel-Briand Y, Cornelis P.

J Bacteriol. 1999 Jun;181(12):3849-51.

4.

Genotypic analysis of Burkholderia cepacia isolates from 13 French cystic fibrosis centers.

Segonds C, Bingen E, Couetdic G, Mathy S, Brahimi N, Marty N, Plesiat P, Michel-Briand Y, Chabanon G.

J Clin Microbiol. 1997 Aug;35(8):2055-60.

5.

Dechlorination of Atrazine by a Rhizobium sp. Isolate.

Bouquard C, Ouazzani J, Prome J, Michel-Briand Y, Plesiat P.

Appl Environ Microbiol. 1997 Mar;63(3):862-6.

6.

Epidemiology of pulmonary colonization with Burkholderia cepacia in cystic fibrosis patients. The French Observatoire Burkholderia cepacia Study Group.

Segonds C, Chabanon G, Couetdic G, Michel-Briand Y, Bingen E.

Eur J Clin Microbiol Infect Dis. 1996 Oct;15(10):841-2. No abstract available.

PMID:
8950569
7.

Pulsed-field gel electrophoresis as an epidemiological tool for clonal identification of Aeromonas hydrophila.

Talon D, Dupont MJ, Lesne J, Thouverez M, Michel-Briand Y.

J Appl Bacteriol. 1996 Mar;80(3):277-82.

PMID:
8852675
8.

Discriminatory power and usefulness of pulsed-field gel electrophoresis in epidemiological studies of Pseudomonas aeruginosa.

Talon D, Cailleaux V, Thouverez M, Michel-Briand Y.

J Hosp Infect. 1996 Feb;32(2):135-45.

PMID:
8666764
9.
10.

Use of pulsed-field gel electrophoresis for investigation of an outbreak of Clostridium difficile infection among geriatric patients.

Talon D, Bailly P, Delmée M, Thouverez M, Mulin B, Iehl-Robert M, Cailleaux V, Michel-Briand Y.

Eur J Clin Microbiol Infect Dis. 1995 Nov;14(11):987-93.

PMID:
8654450
11.

Meningitis and septicemia due to Neisseria cinerea.

Kirchgesner V, Plesiat P, Dupont MJ, Estavoyer JM, Guibourdenche M, Riou JY, Michel-Briand Y.

Clin Infect Dis. 1995 Nov;21(5):1351. No abstract available.

PMID:
8589184
12.

[Pseudomonas aeruginosa septicemia. Host-related risk factors in 82 episodes].

Roche O, Beuhorry-Sassus F, Boillot A, Dupont MJ, Plésiat P, Talon D, Cahn JY, Michel-Briand Y.

Presse Med. 1995 Sep 2-9;24(25):1164-6. French.

PMID:
7567833
13.

Risk factors for nosocomial colonization with multiresistant Acinetobacter baumannii.

Mulin B, Talon D, Viel JF, Vincent C, Leprat R, Thouverez M, Michel-Briand Y.

Eur J Clin Microbiol Infect Dis. 1995 Jul;14(7):569-76.

PMID:
7588840
14.

Nasal carriage of Staphylococcus aureus and cross-contamination in a surgical intensive care unit: efficacy of mupirocin ointment.

Talon D, Rouget C, Cailleaux V, Bailly P, Thouverez M, Barale F, Michel-Briand Y.

J Hosp Infect. 1995 May;30(1):39-49.

PMID:
7665881
15.

Molecular characterization of pyocin S3, a novel S-type pyocin from Pseudomonas aeruginosa.

Duport C, Baysse C, Michel-Briand Y.

J Biol Chem. 1995 Apr 14;270(15):8920-7.

16.

[Listeriosis in patients with malignant hemopathy. 3 cases in the same hospital ward].

Fontan J, Brion A, Deconinck E, Flesch M, Vuillier J, Rozenbaum A, Csaszar M, Dupont MJ, Michel-Briand Y, Cahn JY.

Presse Med. 1995 Jan 7;24(1):23-5. French.

PMID:
7899330
17.

[Bacillus licheniformis meningitis].

Estavoyer JM, Meyer V, Leroy J, Vanlemmens P, Plesiat P, Balvay P, Dupont MJ, Michel-Briand Y.

Ann Med Interne (Paris). 1995;146(5):370. French. No abstract available.

PMID:
8526328
18.

[Organ culture preservation of the human cornea at +31 degrees C and risk of infection].

Erbezci M, Monnot PH, Michel-Briand Y, Masse M, Delbosc B.

J Fr Ophtalmol. 1995;18(2):106-13. French.

PMID:
7738301
19.

Typing of hospital strains of Xanthomonas maltophilia by pulsed-field gel electrophoresis.

Talon D, Bailly P, Leprat R, Godard C, Deconnink E, Cahn JY, Michel-Briand Y.

J Hosp Infect. 1994 Jul;27(3):209-17.

PMID:
7963462
20.

Cloning and characterization of the Inc A/C plasmid RA1 replicon.

Llanes C, Gabant P, Couturier M, Michel-Briand Y.

J Bacteriol. 1994 Jun;176(11):3403-7.

21.

Fluconazole-resistant recurrent oral candidiasis in human immunodeficiency virus-positive patients: persistence of Candida albicans strains with the same genotype.

Millon L, Manteaux A, Reboux G, Drobacheff C, Monod M, Barale T, Michel-Briand Y.

J Clin Microbiol. 1994 Apr;32(4):1115-8.

22.

Replicon typing of 71 multiresistant Serratia marcescens strains.

Llanes C, Couturier M, Asfeld L, Grimont F, Michel-Briand Y.

Res Microbiol. 1994 Jan;145(1):17-25.

PMID:
8090980
23.

Characterization of a novel extended-spectrum beta-lactamase from Pseudomonas aeruginosa.

Nordmann P, Ronco E, Naas T, Duport C, Michel-Briand Y, Labia R.

Antimicrob Agents Chemother. 1993 May;37(5):962-9.

24.

Persistence of Pseudomonas aeruginosa strains in seven cystic fibrosis patients followed over 20 months.

Godard C, Plesiat P, Michel-Briand Y.

Eur J Med. 1993 Feb;2(2):117-20. No abstract available.

PMID:
8258014
25.

[Diagnosis of salmonelloses by titration of anti-lipopolysaccharide antibodies using an ELISA method].

Couetdic G, Estavoyer JM, Plésiat P, Leroy J, Michel-Briand Y.

Presse Med. 1993 Jan 30;22(3):132. French. No abstract available.

PMID:
8493221
26.

Why did infection with Aeromonas hydrophila occur when water contains so many other microorganisms?

Cailleaux V, Dupont MJ, Hory B, Amsallem D, Michel-Briand Y.

Clin Infect Dis. 1993 Jan;16(1):174. No abstract available.

PMID:
8448301
27.

Characterization of imipenem-resistant Pseudomonas aeruginosa strains from cystic fibrosis patients.

Godard C, Leroy J, Michel-Briand Y.

J Antimicrob Chemother. 1992 Nov;30(5):721-4. No abstract available.

PMID:
1493989
28.

[Pseudomonas aeruginosa infection in cystic fibrosis: predominance of a single strain and the influence of antibiotic therapy and the environment].

Michel-Briand Y, Plesiat P, Godard C, Noir A, Estavoyer JM.

Bull Acad Natl Med. 1992 Nov;176(8):1159-69; discussion 1170-1. French.

PMID:
1300222
29.

beta-Lactamase Id of ceftazidime-resistant Pseudomonas aeruginosa strains.

Michel-Briand Y, Nicolas T, Godard C, Plesiat P.

Microbiologica. 1992 Jan;15(1):65-9.

PMID:
1556960
30.

Cloning, sequencing, and expression of the Pseudomonas testosteroni gene encoding 3-oxosteroid delta 1-dehydrogenase.

Plesiat P, Grandguillot M, Harayama S, Vragar S, Michel-Briand Y.

J Bacteriol. 1991 Nov;173(22):7219-27.

31.

[Anti-lipoteichoic acid antibodies in 45 cystic fibrosis patients with Staphylococcus aureus infection].

Couetdic G, Estavoyer JM, Fournier JM, Michel-Briand Y.

Presse Med. 1991 Sep 14;20(28):1342. French. No abstract available.

PMID:
1833743
32.

In-vitro susceptibility pattern and characterization of resistance in Pseudomonas aeruginosa serotype O12 isolated in Belgium in 1986.

Ernst F, Lenoir L, Michel-Briand Y, Van der Auwera P.

J Antimicrob Chemother. 1990 Aug;26(2):298-300. No abstract available.

PMID:
2120179
33.

Stability of conjugative and non-conjugative R-plasmids from Serratia marcescens to gyrase inhibitors.

Llanes C, Michel-Briand Y, Thouverez M, Bailly C, Grimont F.

Microbiologica. 1990 Apr;13(2):157-9.

PMID:
2161994
34.

[Mycobacterium marinum infection].

Estavoyer JM, Leroy J, Courtot S, Michel Briand Y.

Ann Med Interne (Paris). 1990;141(6):561-2. French. No abstract available.

PMID:
2285214
35.

[Pseudomonas aeruginosa septicemia in relation to drug perfusion].

Leprat R, Michel-Briand Y, Thouverez M, Jacquet M, Rozenbaum A, Arlet G, Dupont MJ.

Presse Med. 1989 Oct 7;18(31):1524. French. No abstract available.

PMID:
2530516
36.

Plasmid prevalence in antibiotic resistant Serratia marcescens.

Llanes C, Michel-Briand Y, Bailly C, Grimont F.

J Chemother. 1989 Jul;1(4 Suppl):311-2. No abstract available.

PMID:
16312416
37.

In vitro comparative study of seven macrolides against bacterial strains isolated from bronchial aspirates of hospitalized patients.

Michel-Briand Y, Vieille I.

J Chemother. 1989 Jul;1(4 Suppl):193-4. No abstract available.

PMID:
16312364
38.

[Antibiotic resistance plasmids from Serratia marcescens and their elimination by DNA-gyrase inhibitors].

Llanes C, Michel-Briand Y, Couturier M, Thouverez M, Bailly C.

C R Seances Soc Biol Fil. 1989;183(3):240-6. French.

PMID:
2557972
39.

Prevalence and profiles of plasmids in Pseudomonas aeruginosa.

Plesiat P, Alkhalaf B, Michel-Briand Y.

Eur J Clin Microbiol Infect Dis. 1988 Apr;7(2):261-4.

PMID:
3134228
40.

[Elimination of various virulence plasmids by antibiotics].

Michel-Briand Y, Laporte JM, Dupont MJ, Couetdic G.

Pathol Biol (Paris). 1988 Feb;36(2):159-62. French.

PMID:
3279385
41.

Two presumed novel beta-lactamases in members of the family Enterobacteriaceae.

Deschaseaux ML, Jouvenot M, Adessi GL, Michel-Briand Y.

J Antimicrob Chemother. 1988 Jan;21(1):133-5. No abstract available.

PMID:
3258593
42.

[The role of 4-quinolones and antibiotics in the elimination of virulence plasmids of Enterobacteriaceae].

Michel-Briand Y, Laporte JM, Plesiat P, Sansonetti PJ.

Pathol Biol (Paris). 1987 Dec;35(10 Pt 2):1386-8. French.

PMID:
3325901
43.

Three cases of bacteremia with group Ve-2 bacteria in France.

Couetdic G, Plesiat P, Chambers R, Cahn JY, Michel-Briand Y.

Eur J Clin Microbiol. 1987 Aug;6(4):499-500. No abstract available.

PMID:
3665905
44.

Molecular hybridization versus isoelectric focusing to determine TEM-type beta-lactamases in gram-negative bacteria.

Jouvenot M, Deschaseaux ML, Royez M, Mougin C, Cooksey RC, Michel-Briand Y, Adessi GL.

Antimicrob Agents Chemother. 1987 Feb;31(2):300-5.

45.

Elimination of plasmids from Enterobacteriaceae by 4-quinolone derivatives.

Michel-Briand Y, Uccelli V, Laporte JM, Plesiat P.

J Antimicrob Chemother. 1986 Dec;18(6):667-74.

PMID:
3029010
46.

Elimination of a virulence plasmid from Shigella sonnei and Escherichia coli by antibiotics.

Michel-Briand Y, Laporte JM, Couetdic G, Sansonetti PJ.

Ann Inst Pasteur Microbiol. 1986 Nov-Dec;137B(3):291-5.

PMID:
3318870
47.

Inhibition of conjugal transfer of R plasmids by nitrofurans.

Michel-Briand Y, Laporte JM.

J Gen Microbiol. 1985 Sep;131(9):2281-4.

PMID:
3906037
48.

Development of plasmid-mediated resistance in Vibrio cholerae during treatment with trimethoprim-sulfamethoxazole.

Dupont MJ, Jouvenot M, Couetdic G, Michel-Briand Y.

Antimicrob Agents Chemother. 1985 Feb;27(2):280-1.

49.

[Effects of nitronaphthofurans on the transfer of a plasmid].

Bonnin M, Michel-Briand Y, Royer R, Buisson JP.

Ann Pharm Fr. 1985;43(5):505-12. French. No abstract available.

PMID:
3915195
50.

[Inhibition of the maintenance and transfer of antibiotic-resistance plasmids by quinolones].

Uccelli V, Laporte JM, Michel-Briand Y.

C R Seances Soc Biol Fil. 1985;179(5):696-9. French.

PMID:
2938699

Supplemental Content

Loading ...
Support Center